☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
DURECT Corporation
DURECT Corporation Enters a $136M Licensing Agreement with Innocoll Biotherapeutics for Posimir (Bupivacaine Solution)
December 23, 2021
Insights+: COVID-19 Healthcare News Monthly Updates - September 2020
September 30, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
